Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center.
Parrotta E, Kister I, Charvet L, Sammarco C, Saha V, Charlson RE, Howard J, Gutman JM, Gottesman M, Abou-Fayssal N, Wolintz R, Keilson M, Fernandez-Carbonell C, Krupp LB, Zhovtis Ryerson L. Parrotta E, et al. Among authors: wolintz r. Neurol Neuroimmunol Neuroinflamm. 2020 Jul 9;7(5):e835. doi: 10.1212/NXI.0000000000000835. Print 2020 Sep. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32646885 Free PMC article.
Acute diplopia as the presenting sign of silent sinus syndrome.
Saffra N, Rakhamimov A, Saint-Louis LA, Wolintz RJ. Saffra N, et al. Among authors: wolintz rj. Ophthalmic Plast Reconstr Surg. 2013 Sep-Oct;29(5):e130-1. doi: 10.1097/IOP.0b013e31827bda92. Ophthalmic Plast Reconstr Surg. 2013. PMID: 23274810
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock AW; SENTINEL Investigators. Radue EW, et al. J Neurol Sci. 2010 May 15;292(1-2):28-35. doi: 10.1016/j.jns.2010.02.012. Epub 2010 Mar 16. J Neurol Sci. 2010. PMID: 20236661 Clinical Trial.